After the identification of anti-aquaporin 4 (AQP4) antibodies and recognition of disease-related brain lesions in the area postrema, brainstem and diencephalon, the concept of NMO has been expanded to NMO spectrum disorder (NMOSD) [2]. This evidence concerns the gene AQP4 and neuromyelitis optica.